Author:
Kitsou Chrysoula,Pal Utpal
Reference13 articles.
1. WHO (2016) Vector-borne diseases. http://wwwwhoint/mediacentre/factsheets/fs387/en/
2. Parola P, Raoult D (2001) Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis 32:897–928. https://doi.org/10.1086/319347
3. Marconi RT, Earnhart CG (2010) Lyme disease vaccines. In: Samuels DS, Radolf JD (eds) Borrelia, Molecular Biology, Host Interaction and Pathogenesis. Caister. Academic Press, Norfolk, UK, pp 467–486
4. Kumar M, Kaur S, Kariu T, Yang X, Bossis I, Anderson JF, Pal U (2011) Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine. Vaccine 29(48):9012–9019. https://doi.org/10.1016/j.vaccine.2011.09.035
5. Kung F, Kaur S, Smith AA, Yang X, Wilder CN, Sharma K, Buyuktanir O, Pal U (2016) A Borrelia burgdorferi surface-exposed transmembrane protein lacking detectable immune responses supports pathogen persistence and constitutes a vaccine target. J Infect Dis 213:1786–1795. https://doi.org/10.1093/infdis/jiw013
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献